dx 9065a has been researched along with aspirin in 2 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (aspirin) | Trials (aspirin) | Recent Studies (post-2010) (aspirin) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 48,947 | 6,817 | 13,778 |
| Protein | Taxonomy | dx 9065a (IC50) | aspirin (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.35 | |
| Integrin beta-3 | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.8252 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 1.375 | |
| Integrin alpha-IIb | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.271 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 2.4 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 2.15 | |
| Urotensin-2 receptor | Rattus norvegicus (Norway rat) | 0.3 | |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 2.4 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.35 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4081 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, PW; Becker, RC; Bovill, EG; Dyke, CK; Dzavik, V; Gardner, LH; Gerstenblith, G; Harrington, RA; Hasselblad, V; Hochman, JS; Kleiman, NS; Kunitada, S; Lincoff, AM; Robertson, TL; Shimoto, Y; Zillman, LA | 1 |
| Badimon, JJ; Chen, J; Fuster, V; Kunitada, S; Osende, J; Robbins, J; Shimbo, D; Shimoto, Y | 1 |
2 trial(s) available for dx 9065a and aspirin
| Article | Year |
|---|---|
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Cohort Studies; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa; Factor Xa Inhibitors; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Infusions, Intravenous; International Normalized Ratio; Linear Models; Male; Middle Aged; Naphthalenes; Partial Thromboplastin Time; Propionates; Prothrombin Time; Time Factors | 2002 |
Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin.
Topics: Adult; Aspirin; Blood Coagulation Tests; Cross-Over Studies; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorheology; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Naphthalenes; Propionates; Stress, Mechanical | 2002 |